Kaken Pharmaceutical Co Ltd (4521.T) revealed earnings for full year that Dropped, from the same period last year
The company's earnings came in at JPY2.144 billion, or JPY56.57 per share. This compares with JPY13.945 billion, or JPY365.42 per share, last year.
The company's revenue for the period fell 18.3% to JPY76.871 billion from JPY94.035 billion last year.
Kaken Pharmaceutical Co Ltd earnings at a glance (GAAP) :
-Earnings: JPY2.144 Bln. vs. JPY13.945 Bln. last year.-EPS: JPY56.57 vs. JPY365.42 last year.-Revenue: JPY76.871 Bln vs. JPY94.035 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.